Dr Reddy's Laboratories gained 2.43% to Rs 2,834 at 14:19 IST on BSE after consolidated net profit surged 52.49% to Rs 550.39 crore on 22.67% growth in total income to Rs 3536.02 crore in Q1 June 2014 over Q1 June 2013.
The Q1 result was announced during market hours today, 30 July 2014.
Meanwhile, the S&P BSE Sensex was up 44.30 points or 0.17% at 26,035.53
On BSE, so far 36,147 shares were traded in the counter as against average daily volume of 34,739 shares in the past one quarter.
The stock hit a high of Rs 2,852 and a low of Rs 2,766 so far during the day. The stock had hit a record high of Rs 2,939.80 on 28 February 2014. The stock had hit a 52-week low of Rs 2,025 on 21 August 2013.
The stock had outperformed the market over the past one month till 28 July 2014, rising 8.36% compared with 3.55% rise in the Sensex. The scrip had, however, underperformed the market in past one quarter, rising 3.53% as against Sensex's 14.84% rise.
More From This Section
The large-cap company has equity capital of Rs 85.17 crore. Face value per share is Rs 5.
Dr Reddy's Laboratories is an integrated global pharmaceutical company. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - Dr Reddy's offers a portfolio of products and services including active pharmaceutical ingredients (APIs), custom pharmaceutical services, generics, biosimilars and differentiated formulations.
Powered by Capital Market - Live News